Benjamin Lightburn: Are Natural Psychedelics the Future of Healing? episode artwork

EPISODE · Jan 16, 2025 · 21 MIN

Benjamin Lightburn: Are Natural Psychedelics the Future of Healing?

from 21st Century Entrepreneurship · host Martin Piskoric

Benjamin  Lightburn is a pioneer in the development of natural psychedelic drug candidates. We spoke about his groundbreaking work at Filament Health, where he and his team are redefining how psychedelics are developed and utilized in clinical settings. Benjamin shared his extensive experience in botanical extraction, the challenges of building startups, and the immense potential of psychedelics for treating substance use disorders and other mental health conditions.Throughout the conversation, Benjamin highlighted key distinctions between natural and synthetic drugs. "A natural drug gets extracted from a natural source," he explained, emphasizing that Filament Health’s patented processes allow them to retain the full spectrum of compounds found in psilocybin mushrooms. “We like to think it’s the best of both worlds,” Benjamin remarked, balancing nature’s complexity with pharmaceutical precision.We also discussed the critical importance of sustainability and cultural respect in sourcing plant-based psychedelics. Benjamin described how the Nagoya Protocol helps ensure ethical and equitable practices, particularly for plants like the iboga root, traditionally used by the Bwiti people of West Africa.Key Takeaways:Transformative Potential: Psychedelics have shown remarkable promise in treating substance use disorders, with research showing reductions in heavy drinking days by 83% and high rates of smoking cessation.Natural vs. Synthetic: Natural psychedelics, derived from mushrooms and plants, retain secondary compounds that may enhance therapeutic effects.Sustainability Matters: Ethical sourcing, as governed by protocols like Nagoya, ensures local communities and ecosystems are respected and preserved.Mental Health for Founders: Benjamin shared personal lessons on managing the immense stress of entrepreneurship, stating, “No company is worth the pain you could go through.”This episode provides a thought-provoking look at how natural psychedelics could redefine medicine while emphasizing the need for innovation, compassion, and sustainability. Whether you’re curious about the science, the ethics, or the personal challenges of building a company in this space, Benjamin’s insights are both inspiring and practical.

Episode metadata supplied by the publisher feed · Published Jan 16, 2025

Embed this episode

Benjamin Lightburn is a pioneer in the development of natural psychedelic drug candidates. We spoke about his groundbreaking work at Filament Health, where he and his team are redefining how psychedelics are developed and utilized in clinical settings. Benjamin shared his extensive experience in botanical extraction, the challenges of building startups, and the immense potential of psychedelics for treating substance use disorders and other mental health conditions. Throughout the conve...

Distinct summary based on available episode metadata or transcript content.

NOW PLAYING

Benjamin Lightburn: Are Natural Psychedelics the Future of Healing?

0:00 21:27

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of 21st Century Entrepreneurship?

This episode is 21 minutes long.

When was this 21st Century Entrepreneurship episode published?

This episode was published on January 16, 2025.

Can I download this 21st Century Entrepreneurship episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!